Modalis Therapeutics

Modalis Therapeutics EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Modalis Therapeutics (4883.T) as of Nov 2, 2026 is -2.21 B JPY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -1.34 B JPY — a change of 65.35% (lower).

EBITDA

-2.21 BJPY

YoY

65.35%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Modalis Therapeutics is 2025 -2.21 B JPY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Modalis Therapeutics was 2024 -1.34 B JPY. It decreases by 65.35% lower compared to the previous year.

The Modalis Therapeutics EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-214.12 M JPY
Jan 1, 2019
157.00 M JPY
Jan 1, 2020
-439.55 M JPY
Jan 1, 2021
-745.42 M JPY
Jan 1, 2022
-2.70 B JPY
Jan 1, 2023
-2.37 B JPY
Jan 1, 2024
-1.34 B JPY
Jan 1, 2025
-2.21 B JPY
The Modalis Therapeutics EBITDA history
YEAREBITDAYoY
-2.21 BJPY+65.35%
-1.34 BJPY-43.67%
-2.37 BJPY-12.02%
-2.70 BJPY+262.07%
-745.42 MJPY+69.59%
-439.55 MJPY-379.97%
157.00 MJPY-173.32%
-214.12 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Modalis Therapeutics Stock analysis

What does Modalis Therapeutics do? Modalis Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Modalis Therapeutics stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Modalis Therapeutics is -2.21 B JPY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Modalis Therapeutics changed from -1.34 B JPY to -2.21 B JPY, representing a 65.35% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Modalis Therapeutics since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Modalis Therapeutics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Modalis Therapeutics

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Modalis Therapeutics